Skip to main content

Increased susceptibility to apoptosis and growth arrest of human breast cancer cells treated by a snake venom-loaded silica nanoparticles

Research Authors
Badr G, Sayed D, Maximous D, Mohamed AO, Gul M.
Research Department
Research Journal
Cell Physiol Biochem.
Research Member
Douaa Mohamed Sayed Hussein
Research Pages
1640-51
Research Rank
1
Research Year
2014

Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma.

Research Authors
Mohamed A.Y. Abdel Malek, Sajjeev Jagannathan, Ehsan Malek, Douaa M. Sayed, Sahar A. Elgammal, Hanan G. Abd El-Azeem, Nabila M. Thabet and James J. Driscoll
Research Department
Research Journal
Oncotarget.
Research Member
Douaa Mohamed Sayed Hussein
Research Rank
1
Research Year
2015

Subclinical vascular endothelial dysfunctions and myocardial changes with type 1 diabetes mellitus in children and adolescents.

Research Authors
Azza A. Eltayeb; Faisal-Alkhateeb Ahmad; Douaa M. Sayed; Amany M. Osama
Research Department
Research Journal
Pediatric Cardiology
Research Member
Douaa Mohamed Sayed Hussein
Research Rank
1
Research Year
2014

Superior Hypogastric Plexus Combined with
Ganglion Impar Neurolytic Blocks for Pelvic
and/or Perineal Cancer Pain Relief

Research Abstract
Background: The superior hypogastric plexus (SHGP) carries afferents from the viscera of the lower abdomen and pelvis. Neurolytic block of this plexus is used for reducing pain resulting from malignancy in these organs. The ganglion impar (GI) innervats the perineum, distal rectum, anus, distal urethra, vulva, and distal third of the vagina. Different approaches to the ganglion impar neurolysis have been described in the literature. Objectives: To assess the feasibility, safety, and efficacy of combining the block of the SHGP through the postero-median transdiscal approach with the GI block by the transsacro- coccygeal approach for relief of pelvic and/or perineal pain caused by pelvic and/or perineal malignancies or any cancer related causes. Methods: Fifteen patients who had cancer-related pelvic pain, perineal pain, or both received a combined SHGP neurolytic block through the postero-median transdiscal approach using a 20-gauge Chiba needle and injection of 10 mL of 10% phenol in saline plus a GI neurolytic block by the trans-sacro-coccygeal approach using a 22-gauge 5 cm needle and injection of 4 – 6 mL of 8% phenol in saline. Pain intensity (measured using a visual analogue scale) and oral morphine consumption pre- and post-procedure were measured. Results: All patients presented with cancer-related pelvic, perineal, or pelviperineal pain. Pain scores were reduced from a mean (± SD) of 7.87 ± 1.19 pre-procedurally to 2.40 ± 2.10 one week post-procedurally (P 0.05). In addition, the mean consumption of morphine (delivered via 30 mg sustained-release morphine tablets) was reduced from 98.00 ± 34.89 mg to 32.00 ± 28.48 mg after one week (P 0.05). No complications or serious side effects were encountered during or after the block. Limitations: This study is limited by its small sample size and non-randomized study. Conclusion: A combined neurolytic SHGP block with GI block is an effective and safe technique for reducing pain in cancer patients presented with pelvic and/or perineal pain. Also, a combined SHGP block through a posteromedian transdiscal approach with a GI block through a trans-sacrococcygeal approach may be considered more effective and easier to perform than the recently invented bilateral inferior hypogastric plexus neurolysis through a transsacral approach.
Research Authors
Doaa G. Ahmed, MD, Mohamad F. Mohamad, MD, and Sahar Abd-Elbaky Mohamed, MD
Research Journal
Pain Physician
Research Pages
:E49-E56
Research Rank
1
Research Vol
Vol 18 No 1
Research Year
2015

Superior Hypogastric Plexus Combined with
Ganglion Impar Neurolytic Blocks for Pelvic
and/or Perineal Cancer Pain Relief

Research Abstract
Background: The superior hypogastric plexus (SHGP) carries afferents from the viscera of the lower abdomen and pelvis. Neurolytic block of this plexus is used for reducing pain resulting from malignancy in these organs. The ganglion impar (GI) innervats the perineum, distal rectum, anus, distal urethra, vulva, and distal third of the vagina. Different approaches to the ganglion impar neurolysis have been described in the literature. Objectives: To assess the feasibility, safety, and efficacy of combining the block of the SHGP through the postero-median transdiscal approach with the GI block by the transsacro- coccygeal approach for relief of pelvic and/or perineal pain caused by pelvic and/or perineal malignancies or any cancer related causes. Methods: Fifteen patients who had cancer-related pelvic pain, perineal pain, or both received a combined SHGP neurolytic block through the postero-median transdiscal approach using a 20-gauge Chiba needle and injection of 10 mL of 10% phenol in saline plus a GI neurolytic block by the trans-sacro-coccygeal approach using a 22-gauge 5 cm needle and injection of 4 – 6 mL of 8% phenol in saline. Pain intensity (measured using a visual analogue scale) and oral morphine consumption pre- and post-procedure were measured. Results: All patients presented with cancer-related pelvic, perineal, or pelviperineal pain. Pain scores were reduced from a mean (± SD) of 7.87 ± 1.19 pre-procedurally to 2.40 ± 2.10 one week post-procedurally (P 0.05). In addition, the mean consumption of morphine (delivered via 30 mg sustained-release morphine tablets) was reduced from 98.00 ± 34.89 mg to 32.00 ± 28.48 mg after one week (P 0.05). No complications or serious side effects were encountered during or after the block. Limitations: This study is limited by its small sample size and non-randomized study. Conclusion: A combined neurolytic SHGP block with GI block is an effective and safe technique for reducing pain in cancer patients presented with pelvic and/or perineal pain. Also, a combined SHGP block through a posteromedian transdiscal approach with a GI block through a trans-sacrococcygeal approach may be considered more effective and easier to perform than the recently invented bilateral inferior hypogastric plexus neurolysis through a transsacral approach.
Research Authors
Doaa G. Ahmed, MD, Mohamad F. Mohamad, MD, and Sahar Abd-Elbaky Mohamed, MD
Research Journal
Pain Physician
Research Member
Sahar Abdel Baky Mohamed Ahmad
Research Pages
:E49-E56
Research Rank
1
Research Vol
Vol 18 No 1
Research Year
2015

Superior Hypogastric Plexus Combined with
Ganglion Impar Neurolytic Blocks for Pelvic
and/or Perineal Cancer Pain Relief

Research Abstract
Background: The superior hypogastric plexus (SHGP) carries afferents from the viscera of the lower abdomen and pelvis. Neurolytic block of this plexus is used for reducing pain resulting from malignancy in these organs. The ganglion impar (GI) innervats the perineum, distal rectum, anus, distal urethra, vulva, and distal third of the vagina. Different approaches to the ganglion impar neurolysis have been described in the literature. Objectives: To assess the feasibility, safety, and efficacy of combining the block of the SHGP through the postero-median transdiscal approach with the GI block by the transsacro- coccygeal approach for relief of pelvic and/or perineal pain caused by pelvic and/or perineal malignancies or any cancer related causes. Methods: Fifteen patients who had cancer-related pelvic pain, perineal pain, or both received a combined SHGP neurolytic block through the postero-median transdiscal approach using a 20-gauge Chiba needle and injection of 10 mL of 10% phenol in saline plus a GI neurolytic block by the trans-sacro-coccygeal approach using a 22-gauge 5 cm needle and injection of 4 – 6 mL of 8% phenol in saline. Pain intensity (measured using a visual analogue scale) and oral morphine consumption pre- and post-procedure were measured. Results: All patients presented with cancer-related pelvic, perineal, or pelviperineal pain. Pain scores were reduced from a mean (± SD) of 7.87 ± 1.19 pre-procedurally to 2.40 ± 2.10 one week post-procedurally (P 0.05). In addition, the mean consumption of morphine (delivered via 30 mg sustained-release morphine tablets) was reduced from 98.00 ± 34.89 mg to 32.00 ± 28.48 mg after one week (P 0.05). No complications or serious side effects were encountered during or after the block. Limitations: This study is limited by its small sample size and non-randomized study. Conclusion: A combined neurolytic SHGP block with GI block is an effective and safe technique for reducing pain in cancer patients presented with pelvic and/or perineal pain. Also, a combined SHGP block through a posteromedian transdiscal approach with a GI block through a trans-sacrococcygeal approach may be considered more effective and easier to perform than the recently invented bilateral inferior hypogastric plexus neurolysis through a transsacral approach.
Research Authors
Doaa G. Ahmed, MD, Mohamad F. Mohamad, MD, and Sahar Abd-Elbaky Mohamed, MD
Research Journal
Pain Physician
Research Member
Research Pages
:E49-E56
Research Rank
1
Research Vol
Vol 18 No 1
Research Year
2015

The Effect of Anesthetic Technique on Cardiac Troponin-T and Systemic Inflammatory Response after Major Abdominal Cancer Surgery

Research Abstract
Objectives: this study aims at assessment of acute infammatory response; measured by high sensitivity C-reactive protein (hs-CRP), and myocardial injury; measured by serum cardiac troponin-T (Tn-T) in patients undergoing elective major abdominal cancer surgery with general anaesthesia or combined general and lumbar epidural anesthesia. Methods: The study included 60 ischemic patients undergoing elective major abdominal cancer surgery with risk factor(s) like(history of myocardial infraction, diabetes, hypertension, obesity or heavy smoking)randomly assigned into 2 groups; 30 patients each to receive general anesthesia (G1) or combined general and epidural anesthesia (G2). Pain severity, time to frst request of rescue analgesic, analgesic consumption, hemodynamics and side effects were recorded in frst 72 hrs postoperative. Serum Tn-T and hs-CRP, ECG were assessed peroperatively and 1,2,3 days postoperativly also 12-lead ECGs were recorded before and 1,2,3 days after surgery. Results: The mean VAS scores were signifcantly reduced in G2 allover time in comparison to G1 (p0.05) except at 32hrs postoperatively. Mean time to frst request for rescue analgesic was signifcantly prolonged in G2 compared to G1 (p=0.001). Mean morphine consumption was signifcantly reduced in G2 (p0.001). Mean serum level of CPR increased in both groups. Mean level of serum troponin-T was signifcantly increased only in G1 compared to baseline value (p0.05) with no signifcant difference between G1 and G2. There were 5 patients (16.6%) in G1 and 2 patients (6.6%) in G2 showed serum troponin-T level > 0.03ng/ml. Regarding ECGs changes there were 2 patients (6.6%) in G1 and one patient (3.3%) in G2 showed new ischemic changes postoperatively in the form of depressed ST segment >1mm. Conclusion: The use of LEA with general anesthesia in high risk patients with ischemic heart disease undergoing major non-cardiac surgery is associated with less perioperative acute infammatory response, less post-operative pain and can reduce the perioperative myocardial damage.
Research Authors
Sahar A Mohamed1*, Khaled M Fares1, Hosam Hasan-Ali2 and Rania Bakry3
Research Journal
Anesthesia & Clinical
Research
Research Pages
1-6
Research Rank
1
Research Vol
Vol 4 No 3
Research Year
2013

The Effect of Anesthetic Technique on Cardiac Troponin-T and Systemic Inflammatory Response after Major Abdominal Cancer Surgery

Research Abstract
Objectives: this study aims at assessment of acute infammatory response; measured by high sensitivity C-reactive protein (hs-CRP), and myocardial injury; measured by serum cardiac troponin-T (Tn-T) in patients undergoing elective major abdominal cancer surgery with general anaesthesia or combined general and lumbar epidural anesthesia. Methods: The study included 60 ischemic patients undergoing elective major abdominal cancer surgery with risk factor(s) like(history of myocardial infraction, diabetes, hypertension, obesity or heavy smoking)randomly assigned into 2 groups; 30 patients each to receive general anesthesia (G1) or combined general and epidural anesthesia (G2). Pain severity, time to frst request of rescue analgesic, analgesic consumption, hemodynamics and side effects were recorded in frst 72 hrs postoperative. Serum Tn-T and hs-CRP, ECG were assessed peroperatively and 1,2,3 days postoperativly also 12-lead ECGs were recorded before and 1,2,3 days after surgery. Results: The mean VAS scores were signifcantly reduced in G2 allover time in comparison to G1 (p0.05) except at 32hrs postoperatively. Mean time to frst request for rescue analgesic was signifcantly prolonged in G2 compared to G1 (p=0.001). Mean morphine consumption was signifcantly reduced in G2 (p0.001). Mean serum level of CPR increased in both groups. Mean level of serum troponin-T was signifcantly increased only in G1 compared to baseline value (p0.05) with no signifcant difference between G1 and G2. There were 5 patients (16.6%) in G1 and 2 patients (6.6%) in G2 showed serum troponin-T level > 0.03ng/ml. Regarding ECGs changes there were 2 patients (6.6%) in G1 and one patient (3.3%) in G2 showed new ischemic changes postoperatively in the form of depressed ST segment >1mm. Conclusion: The use of LEA with general anesthesia in high risk patients with ischemic heart disease undergoing major non-cardiac surgery is associated with less perioperative acute infammatory response, less post-operative pain and can reduce the perioperative myocardial damage.
Research Authors
Sahar A Mohamed1*, Khaled M Fares1, Hosam Hasan-Ali2 and Rania Bakry3
Research Department
Research Journal
Anesthesia & Clinical
Research
Research Pages
1-6
Research Rank
1
Research Vol
Vol 4 No 3
Research Year
2013

The Effect of Anesthetic Technique on Cardiac Troponin-T and Systemic Inflammatory Response after Major Abdominal Cancer Surgery

Research Abstract
Objectives: this study aims at assessment of acute infammatory response; measured by high sensitivity C-reactive protein (hs-CRP), and myocardial injury; measured by serum cardiac troponin-T (Tn-T) in patients undergoing elective major abdominal cancer surgery with general anaesthesia or combined general and lumbar epidural anesthesia. Methods: The study included 60 ischemic patients undergoing elective major abdominal cancer surgery with risk factor(s) like(history of myocardial infraction, diabetes, hypertension, obesity or heavy smoking)randomly assigned into 2 groups; 30 patients each to receive general anesthesia (G1) or combined general and epidural anesthesia (G2). Pain severity, time to frst request of rescue analgesic, analgesic consumption, hemodynamics and side effects were recorded in frst 72 hrs postoperative. Serum Tn-T and hs-CRP, ECG were assessed peroperatively and 1,2,3 days postoperativly also 12-lead ECGs were recorded before and 1,2,3 days after surgery. Results: The mean VAS scores were signifcantly reduced in G2 allover time in comparison to G1 (p0.05) except at 32hrs postoperatively. Mean time to frst request for rescue analgesic was signifcantly prolonged in G2 compared to G1 (p=0.001). Mean morphine consumption was signifcantly reduced in G2 (p0.001). Mean serum level of CPR increased in both groups. Mean level of serum troponin-T was signifcantly increased only in G1 compared to baseline value (p0.05) with no signifcant difference between G1 and G2. There were 5 patients (16.6%) in G1 and 2 patients (6.6%) in G2 showed serum troponin-T level > 0.03ng/ml. Regarding ECGs changes there were 2 patients (6.6%) in G1 and one patient (3.3%) in G2 showed new ischemic changes postoperatively in the form of depressed ST segment >1mm. Conclusion: The use of LEA with general anesthesia in high risk patients with ischemic heart disease undergoing major non-cardiac surgery is associated with less perioperative acute infammatory response, less post-operative pain and can reduce the perioperative myocardial damage.
Research Authors
Sahar A Mohamed1*, Khaled M Fares1, Hosam Hasan-Ali2 and Rania Bakry3
Research Journal
Anesthesia & Clinical
Research
Research Member
Sahar Abdel Baky Mohamed Ahmad
Research Pages
1-6
Research Rank
1
Research Vol
Vol 4 No 3
Research Year
2013

The Effect of Anesthetic Technique on Cardiac Troponin-T and Systemic Inflammatory Response after Major Abdominal Cancer Surgery

Research Abstract
Objectives: this study aims at assessment of acute infammatory response; measured by high sensitivity C-reactive protein (hs-CRP), and myocardial injury; measured by serum cardiac troponin-T (Tn-T) in patients undergoing elective major abdominal cancer surgery with general anaesthesia or combined general and lumbar epidural anesthesia. Methods: The study included 60 ischemic patients undergoing elective major abdominal cancer surgery with risk factor(s) like(history of myocardial infraction, diabetes, hypertension, obesity or heavy smoking)randomly assigned into 2 groups; 30 patients each to receive general anesthesia (G1) or combined general and epidural anesthesia (G2). Pain severity, time to frst request of rescue analgesic, analgesic consumption, hemodynamics and side effects were recorded in frst 72 hrs postoperative. Serum Tn-T and hs-CRP, ECG were assessed peroperatively and 1,2,3 days postoperativly also 12-lead ECGs were recorded before and 1,2,3 days after surgery. Results: The mean VAS scores were signifcantly reduced in G2 allover time in comparison to G1 (p0.05) except at 32hrs postoperatively. Mean time to frst request for rescue analgesic was signifcantly prolonged in G2 compared to G1 (p=0.001). Mean morphine consumption was signifcantly reduced in G2 (p0.001). Mean serum level of CPR increased in both groups. Mean level of serum troponin-T was signifcantly increased only in G1 compared to baseline value (p0.05) with no signifcant difference between G1 and G2. There were 5 patients (16.6%) in G1 and 2 patients (6.6%) in G2 showed serum troponin-T level > 0.03ng/ml. Regarding ECGs changes there were 2 patients (6.6%) in G1 and one patient (3.3%) in G2 showed new ischemic changes postoperatively in the form of depressed ST segment >1mm. Conclusion: The use of LEA with general anesthesia in high risk patients with ischemic heart disease undergoing major non-cardiac surgery is associated with less perioperative acute infammatory response, less post-operative pain and can reduce the perioperative myocardial damage.
Research Authors
Sahar A Mohamed1*, Khaled M Fares1, Hosam Hasan-Ali2 and Rania Bakry3
Research Journal
Anesthesia & Clinical
Research
Research Member
Khaled Mohamed Fares Ali
Research Pages
1-6
Research Rank
1
Research Vol
Vol 4 No 3
Research Year
2013
Subscribe to